Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    Anagenics' signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum
    • News

  • BWX revises its FY23 forecast, following ASX suspension and eCommerce decline
    BWX revises its FY23 forecast, following ASX suspension and eCommerce decline
    • News

  • RooLife signed for AI marketing of skincare products to Chinese customers
    RooLife signed for AI marketing of skincare products to Chinese customers
    • News

  • Saferoads partners with TrafFix Devices for distribution of road barriers to North America
    • News

    Saferoads partners with TrafFix Devices for distribution of road barriers to North America

    The only unanchored temporary barrier in the world to have successfully passed rigorous MASH TL-4 test will soon be deployed in North America with manufacturing company Saferoads (ASX: SRH) selecting TrafFix Devices as their exclusive distributor.  The exclusive distribution agreement covering North America will allow TrafFix Devices, an American manufacturer of highway safety products, to

    Read More
    Public
  • Top Shelf secured $5m from sale of Whitsundays agave farmland for debt reduction
    • News

    Top Shelf secured $5m from sale of Whitsundays agave farmland for debt reduction

    Australian spirits producer and distributor Top Shelf International (ASX: TSI) has executed a binding term sheet for a $5 million sale and leaseback transaction of the farmland and structural improvement assets at the Company’s agave farm in Eden Lassie, Queensland’s Whitsundays region. The agreement does not cover the farm’s distillery plant and equipment assets or

    Read More
    Public
  • Hit the Butn: B2B lender sees platform growth with rise in new SME registrations
    • News

    Hit the Butn: B2B lender sees platform growth with rise in new SME registrations

    There are over two million small and medium-sized businesses peppered across Australia, making up over 97% of all businesses in the country. However, many struggle to survive primarily because of cash flow issues. That’s where B2B funder Butn (ASX: BTN) comes in, helping SMEs manage their finances.  In Q3 FY24, ending March 2024, the Company

    Read More
    Public
  • Genetic Technologies to pilot GeneType in US breast screening centres
    • News

    Genetic Technologies to pilot GeneType in US breast screening centres

    Molecular diagnostics company Genetic Technologies (ASX: GTG) is piloting its risk assessment test geneType in breast screening centres across the US. The Company is establishing a clinical implementation study with breast imaging centres in New York, Miami and Houston.  In the US, screening is currently between the ages of 40 and 74. So, the current

    Read More
    Public
  • SciDev to provide water treatment solutions to Ventia in $2m revenue opportunity
    • News

    SciDev to provide water treatment solutions to Ventia in $2m revenue opportunity

    Water tech company SciDev Limited (ASX: SDV) has been engaged by infrastructure services provider Ventia to undertake water treatment services in Victoria. The Company will supply a Build Own Operate (BOO) temporary water treatment plant in Victoria to treat PFAS-contaminated surface water. The contract’s initial revenue value is approximately $2 million, which is anticipated to

    Read More
    Public
  • RocketDNA deploys first batch of xBots for Australia and Africa, second batch scheduled
    • News

    RocketDNA deploys first batch of xBots for Australia and Africa, second batch scheduled

    Global drones-as-a-service provider RocketDNA (ASX: RKT) recently launched a new autonomous drone solution, xBot, expected to surpass its existing drone business in revenue.  In December 2023, the Company raised approximately $1 million to accelerate the manufacturing of xBot units and increase marketing capabilities around deployment. It has successfully launched and deployed the first batch of

    Read More
    Public
  • Hong Kong authorities dismiss case into Credit Intelligence brought upon by former CEO and Founder
    • News

    Hong Kong authorities dismiss case into Credit Intelligence brought upon by former CEO and Founder

    The Hong Kong Official Receiver’s Office (ORO) has concluded its investigation into the allegations made by Mr. Ka Sek Wong (Jimmie Wong), the former CEO of Credit Intelligence (ASX: CI1), finding no evidence of material irregularity in the Company’s operations. This outcome follows a turbulent period for Credit Intelligence, marked by legal actions and complaints

    Read More
    Public
  • Novatti lands client wins from food delivery and BNPL sectors, alongside payments growth in New Zealand
    • News

    Novatti lands client wins from food delivery and BNPL sectors, alongside payments growth in New Zealand

    Since commencing a strategic business transformation just 9 months ago, digital payments company Novatti Group (ASX: NOV) has reported progressive results of their pivot to a market and customer-centric approach which has yielded new business from major players in the BNPL, food delivery, accounting and accommodation sectors.  The implementation of a market and customer-led strategy

    Read More
    Public
  • Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic
    • News

    Melodiol’s Health House Australia enlists supplier, prepares for the launch of a medical cannabis clinic

    Over the past several months, medical cannabis company Melodiol Global Health’s (ASX: ME1) subsidiary Health House Australia has been gearing up for the launch of its medicinal cannabis clinic.  After significant internal analysis and planning, Health House Australia expects the Health House Wellness Clinic to be operational in Q2 of CY24. The Health House Wellness

    Read More
    Public
  • Preclinical data indicates Patrys’s therapeutic safely reduces inflammation in autoimmune disease
    • News

    Preclinical data indicates Patrys’s therapeutic safely reduces inflammation in autoimmune disease

    Melbourne-based therapeutic antibody development company Patrys (ASX: PAB) unveiled positive findings from preclinical studies using PAT-DX1 and PAT-DX3 in animal anti-neutrophil cytoplasmic antibody (ANCA) vasculitis models.  Dr Kim O’Sullivan from Monash University presented the findings during the plenary session at the 21st International Vasculitis Workshop in Barcelona. He said, “Both PAT-DX1 and PAT-DX3 are able

    Read More
    Public
  • «
  • ‹
  • 46
  • 47
  • 48
  • 49
  • 50
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.